Trial Profile
A Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of An Anticholinergic Agent for the Treatment of Primary Axillary Hyperhidrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2014
Price :
$35
*
At a glance
- Drugs WL 8713 (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Actavis Inc
- 13 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jul 2014 New trial record